Fidelity Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11M Buy
509,113
+189,234
+59% +$4.11M ﹤0.01% 1895
2025
Q1
$7.76M Buy
319,879
+207,397
+184% +$5.03M ﹤0.01% 2007
2024
Q4
$2.35M Buy
112,482
+13,902
+14% +$290K ﹤0.01% 2391
2024
Q3
$1.96M Buy
98,580
+19,270
+24% +$383K ﹤0.01% 2407
2024
Q2
$1.23M Buy
79,310
+5,480
+7% +$84.9K ﹤0.01% 2463
2024
Q1
$1.18M Buy
73,830
+60,906
+471% +$971K ﹤0.01% 2461
2023
Q4
$217K Sell
12,924
-18,107
-58% -$304K ﹤0.01% 2940
2023
Q3
$363K Sell
31,031
-41,833
-57% -$489K ﹤0.01% 2715
2023
Q2
$979K Buy
72,864
+57,019
+360% +$766K ﹤0.01% 2480
2023
Q1
$263K Buy
15,845
+301
+2% +$4.99K ﹤0.01% 2890
2022
Q4
$289K Sell
15,544
-26,905
-63% -$500K ﹤0.01% 2896
2022
Q3
$544K Buy
42,449
+38,231
+906% +$490K ﹤0.01% 2760
2022
Q2
$30K Buy
4,218
+822
+24% +$5.85K ﹤0.01% 3744
2022
Q1
$28K Buy
3,396
+1,377
+68% +$11.4K ﹤0.01% 3892
2021
Q4
$14K Sell
2,019
-400
-17% -$2.77K ﹤0.01% 3545
2021
Q3
$12K Buy
2,419
+1,266
+110% +$6.28K ﹤0.01% 3561
2021
Q2
$7K Sell
1,153
-647
-36% -$3.93K ﹤0.01% 3625
2021
Q1
$8K Hold
1,800
﹤0.01% 3428
2020
Q4
$6K Hold
1,800
﹤0.01% 3398
2020
Q3
$5K Buy
1,800
+1,082
+151% +$3.01K ﹤0.01% 3307
2020
Q2
$4K Buy
718
+575
+402% +$3.2K ﹤0.01% 3261
2020
Q1
$1K Sell
143
-60
-30% -$420 ﹤0.01% 3467
2019
Q4
$1K Hold
203
﹤0.01% 3629
2019
Q3
$1K Sell
203
-343
-63% -$1.69K ﹤0.01% 3628
2019
Q2
$2K Buy
+546
New +$2K ﹤0.01% 3507
2018
Q1
Sell
-300,000
Closed -$1.17M 2674
2017
Q4
$1.17M Hold
300,000
﹤0.01% 2428
2017
Q3
$756K Hold
300,000
﹤0.01% 2440
2017
Q2
$828K Buy
+300,000
New +$828K ﹤0.01% 2452